Related Experiment Video
Updated: Jul 4, 2025
06:45
Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
Published on: October 4, 2021
2.8K
Chronic dizziness in restless legs syndrome (RLS) patients responsive to levodopa or dopamine agonists
Sanjay Prakash1, Harsh Patel2, Chetsi Sudhir Shah2
1Neurolgy, SBKS Medical Institute and Research Centre, Sumandeep Vidyapeeth, Vadodara, India drprakashs@yahoo.co.in.
BMJ Case Reports
|January 29, 2024
Summary
Restless legs syndrome (RLS) can affect more than just the legs, potentially causing head symptoms perceived as dizziness. Treatment with dopamine agonists relieved RLS and dizziness in two patients.
Area of Science:
- Neurology
- Sleep Medicine
Background:
- Restless Legs Syndrome (RLS) is a neurological disorder affecting limbs, but its potential to cause head and facial symptoms is less understood.
- The association between RLS and chronic dizziness has not been previously investigated.
- RLS is known to be comorbid with other conditions, such as headache disorders.
Observation:
- Two patients with a history of chronic dizziness were diagnosed with Restless Legs Syndrome.
- These patients experienced RLS symptoms beyond the typical leg involvement, including in the head and neck regions.
- The patients' dizziness was a prominent feature of their condition.
Findings:
- Treatment with levodopa or dopamine agonists resulted in the complete resolution of both RLS symptoms and chronic dizziness in the observed patients.
- This suggests a potential link between RLS and dizziness, possibly due to RLS-like sensations in the head.
- Dizziness may represent an underrecognized symptom within the broader spectrum of RLS.
Implications:
- Chronic dizziness may be an undiagnosed manifestation of Restless Legs Syndrome in some individuals.
- Clinicians should consider screening for RLS in patients presenting with chronic, unexplained dizziness.
- Dopamine agonist therapy may be a potential treatment option for patients with co-occurring RLS and dizziness, warranting further investigation.
Related Concept Videos
01:27Restless Leg Syndrome and Night Terrors
178
Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
178
01:24Parkinson's Disease: Treatment
268
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
01:28Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
323
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
323
01:15REM Sleep Behavior Disorder
187
REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...
RBD is significantly associated with...
187
01:15Parkinson's Disease: Overview
547
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
547
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
291
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
291